- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05790278
Purpose in Life Survey (PIL)
Evaluating the Prevalence of Purpose-related Existential Distress Among 2 Clinical Populations Compared to a Normative Sample
At present, there is no empirical data that specifies the likely prevalence of purpose in life disruption among various clinical populations. Between one-third and one-half of cancer survivors report some degree of existential distress during or after their treatment, but these findings are not specific to the domain of purpose in life.
To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Abbott Northwestern Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18+
- Stage 1, 2, 3 cancer
- Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer
- Receiving oncology services or treatment through AHCI
- Have completed primary cancer treatment within the past 12 months
- Able to communicate in English;
- Able to see and read (with or without assistive devices);
- Has access to a device (computer, phone, tablet) and an email address;
- Access to an internet connection.
- Has a known email address (in EPIC) and/or home telephone number
- Adults who sustained a traumatic brain injury within the past 12 months.
- Attending the 2022 MN State Fair
Exclusion Criteria:
- Have declined consent for use of medical records in research during admission to AH facility
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adults with Early Stage Cancer
|
Completion of a Purpose in Life Survey
|
|
Adults with Traumatic Brain Injury
|
Completion of a Purpose in Life Survey
|
|
Health Control Adults
|
Completion of a Purpose in Life Survey
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Purpose Status Question
Time Frame: Through Study Completion, about 15 minutes
|
A single forced-choice self-report screener question that we developed in order to characterize existential distress related to purpose in life (PSQ: "Related to living with purpose in life, right now I am: moving backwards; stalled; figuring it out; moving forward on a path").
|
Through Study Completion, about 15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Work and Adjustment Scale
Time Frame: Through Study Completion, about 15 minutes
|
A 5-item self-report questionnaire to characterize functioning related to work, social life, leisure, home management, and relationships.
|
Through Study Completion, about 15 minutes
|
|
Meaning in Life Questionnaire
Time Frame: Through Study Completion, about 15 minutes
|
A 10-item questionnaire designed to measure 2 dimensions of meaning in life: Presence of Meaning (how much respondents feel their lives have meaning) and Search for Meaning (how much respondents strive to find meaning and understanding in their lives).
|
Through Study Completion, about 15 minutes
|
|
Life Engagement Test
Time Frame: Through Study Completion, about 15 minutes
|
A 6-item self-report questionnaire that captures the extent to which a person engages in activities that are personally valued.
|
Through Study Completion, about 15 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mary V Radomski, PhD, Allina Health - Courage Kenny Rehabilitation Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1920306
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.